NL-OMON45496已完成不适用
A phase 1, randomized, placebo-controlled study to assess the safety and pharmacokinetics of multiple ascending dose regimens of TP-6076. - TP-6076 MAD study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Healthy male or female
- •18-55 years, inclusive
- •BMI 18.0-35.0 kilogram/meter2
- •Weight between 50 (female) and 60 (male) and 105 kilograms, inclusive
- •Non smokers
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
研究者
相似试验
已完成
不适用
A Phase 1, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses Oral Doses of APX001, to Investigate the Effect of Food on APX001 and to Investigate the Drug-Drug Interaction Potential of APX001Fungal infectionNL-OMON45345Amplyx Pharmaceuticals, Inc.46
已完成
1 期
A trial of BIT225 in patients with HIV-1 infection, to study the safety, concentration and distribution in the body, and anti-viral activity of the drug.ACTRN12612000696897Biotron Limited24
招募中
1 期
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of PLX-4545 in Healthy VolunteersSolid TumoursCancer - Any cancerACTRN12623001265662Plexium Australia Pty Ltd96
进行中（未招募）
不适用
Study comparing the effect on pain and function of an anaesthetic injection with a placebo (non-active substance) for the treatment of pain at the trapezius muscle.Trapezius muscle pain in patients with fibromyalgiaMedDRA version: 18.0Level: PTClassification code 10048439Term: FibromyalgiaSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2015-000796-28-ESFundacio Clinic per a la Recerca Biomèdica
招募中
1 期
A Study to Evaluate the Safety of a Single and Multiple Oral Doses of a Biologic Therapy (MB-001) or placebo in Healthy Human Participantslcerative colitisOral and Gastrointestinal - Inflammatory bowel diseaseUlcerative colitisACTRN12624000524594Mage Biologics48